Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Pak J Med Sci ; 39(6): 1690-1694, 2023.
Article in English | MEDLINE | ID: mdl-37936785

ABSTRACT

Objective: To evaluate the value of cardiac troponin(cTn), myoglobin(Myo) combined with heart-type fatty acid-binding protein(H-FABP) detection in the diagnosis of early acute myocardial infarction(AMI). Methods: This study was a clinical comparative study. Eighty patients with AMI hospitalized in Tangshan Workers' Hospital were selected as study group, and another 80 individuals receiving normal physical examination were selected as control group from September 20, 2021 to September 20, 2022. The concentrations of cTn, Myo and H-FABPP, diagnostic indicators, the sensitivity and specificity of combined diagnosis, as well as the diagnostic efficacy for AMI were compared between the two groups. Results: The levels of cTn, Myo and H-FABPP in the study group were significantly higher than those in the control group(P= 0.00). Multivariate logistic regression analysis showed that cTn, Myo and H-FABP were all relevant indicators for AMI. H-FABP alone has better diagnostic efficacy for AMI. The area under the curve of their combined detection, the specificity, and the sensitivity were higher than those of cTn, Myo and H-FABP alone, indicating that their combined application has the best diagnostic efficiency. cTn, Myo and H-FABP levels were positively correlated with Glu, TC, LDL-C and hs-CRP levels(P< 0.01), while negatively correlated with HDL level(P< 0.01). Conclusions: The combined detection of cardiac markers such as cTn, Myo and H-FABP presents higher sensitivity and specificity in the diagnosis of AMI compared with any single detection, and can provide better data support for the definite diagnosis of AMI, with high clinical application value.

2.
Zhongguo Dang Dai Er Ke Za Zhi ; 24(7): 765-770, 2022 Jul 15.
Article in Chinese | MEDLINE | ID: mdl-35894191

ABSTRACT

OBJECTIVES: To study the value of autotaxin (an autocrine motility factor) level in serum and bronchoalveolar lavage fluid (BALF) in predicting refractory Mycoplasma pneumoniae pneumonia (RMPP) in children and its correlation with interleukin-6 (IL-6), interleukin-8 (IL-8), and C-reactive protein (CRP). METHODS: A retrospective analysis was performed on 238 children with Mycoplasma pneumoniae pneumonia who were admitted from January 2019 to December 2021. According to disease severity, they were divided into two groups: RMPP (n=82) and general Mycoplasma pneumoniae pneumonia (GMPP; n=156). The two groups were compared in terms of the levels of autotaxin, IL-6, IL-8, and CRP in serum and BALF to study the value of autotaxin level in serum and BALF in predicting RMPP in children, as well as the correlation of autotaxin level with IL-6, IL-8, and CRP in children with RMPP. RESULTS: Compared with the GMPP group, the RMPP group had significantly higher levels of autotaxin, IL-6, IL-8, and CRP in serum and BALF (P<0.05). For the children with RMPP, the levels of autotaxin, IL-6, IL-8, and CRP in serum and BALF in the acute stage were significantly higher than those in the convalescent stage (P<0.05). The receiver operating characteristic (ROC) curve showed that the level of autotaxin in serum and BALF had a good value in predicting RMPP in children, with an area under the curve of 0.874 (95%CI: 0.816-0.935) and 0.862 (95%CI: 0.802-0.924), respectively. The correlation analysis showed that the level of autotaxin in serum and BALF was positively correlated with IL-6, IL-8, and CRP levels (P<0.001). CONCLUSIONS: The level of autotaxin in serum and BALF increases and is correlated with the degree of disease recovery and inflammatory cytokines in children with RMPP. Autotaxin can be used as a predictive indicator for RMPP in children.


Subject(s)
Mycoplasma pneumoniae , Pneumonia, Mycoplasma , C-Reactive Protein , Child , Cytokines , Humans , Interleukin-6 , Interleukin-8 , Pneumonia, Mycoplasma/diagnosis , Retrospective Studies
3.
Biol Reprod ; 103(5): 1085-1098, 2020 10 29.
Article in English | MEDLINE | ID: mdl-32776126

ABSTRACT

Women with polycystic ovary syndrome (PCOS) are characterized by endocrine disorders accompanied by a decline in oocyte quality. In this study, we generated a PCOS mice model by hypodermic injection of dehydroepiandrosterone, and metformin was used as a positive control drug to study the effect of pachymic acid (PA) on endocrine and oocyte quality in PCOS mice. Compared with the model group, the mice treated with PA showed the following changes (slower weight gain, improved abnormal metabolism; increased development potential of GV oocytes, reduced number of abnormal MII oocytes, and damaged embryos; lower expression of ovarian-related genes in ovarian tissue and pro-inflammatory cytokines in adipose tissue). All these aspects show similar effects on metformin. Most notably, PA is superior to metformin in improving inflammation of adipose tissue and mitochondrial abnormalities. It is suggested that PA has the similar effect with metformin, which can improve the endocrine environment and oocyte quality of PCOS mice. These findings suggest that PA has the similar effect with metformin, which can improve the endocrine environment and oocyte quality of PCOS mice.


Subject(s)
Oocytes/drug effects , Ovary/drug effects , Polycystic Ovary Syndrome/metabolism , Triterpenes/pharmacology , Animals , Dehydroepiandrosterone , Disease Models, Animal , Female , Metformin/pharmacology , Mice , Oocytes/metabolism , Ovary/metabolism , Polycystic Ovary Syndrome/chemically induced
4.
Environ Int ; 135: 105338, 2020 02.
Article in English | MEDLINE | ID: mdl-31841806

ABSTRACT

Fine particulate matter (PM2.5) has an adverse effect on reproductive function, in particular causing reduced male reproductive function, but relatively few studies have directly targeted its effects on female reproduction. To investigate the effects of PM2.5 exposure on female reproduction, we exposed female mice to PM2.5 by intratracheal instillation for 28 days, and evaluated apoptosis of ovarian granulosa cells and oocytes and the quality embryos after insemination. Our results showed increased numbers of apoptotic granulosa cells and oocytes after exposure to elevated concentrations of PM2.5, which had adverse effects on female fertility via compromising embryo development and quality. We conclude that PM2.5 induced apoptosis of ovarian granulosa cells and oocytes leading to disrupted embryo development and female fertility in mice.


Subject(s)
Air Pollutants , Oocytes , Particulate Matter , Animals , Apoptosis , Female , Male , Mice , Oocytes/drug effects , Oocytes/growth & development , Particulate Matter/toxicity , Reproduction
5.
Medicine (Baltimore) ; 97(28): e11223, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29995754

ABSTRACT

BACKGROUND: The influence of the subglottic secretion drainage (SSD) on the microorganisms of ventilator associated pneumonia (VAP) is still unclear.A meta-analysis focusing on the influence of the SSD on the microorganisms of VAP. METHODS: A comprehensive search was conducted through the online studies of PubMed, Embase, Cochrane Library, Google scholar, CNKI (China National Knowledge Infrastructure), and VIPI (Database for Chinese Technical Periodicals) using specific search terms.Included studies were randomized controlled trials (RCTs) that compare the microorganisms of VAP between SSD and standard endotracheal tube care in mechanically ventilated adults. RESULTS: Nine RCTs were eligible. There was no significant difference in the rate of VAP caused by nonfermentative bacteria and enterobacteria between SSD group and control group (OR = 0.73, 95%CI, 0.53-1.01; P = .06). The episodes of VAP caused by Gram-positive cocci and Haemophilus influenzae organisms were lower in the SSD group (OR = 0.29, 95%CI, 0.18-0.48; P<0.00001). Less mean volume of SSD daily was observed in VAP group (OR = -16.97, 95%CI, -29.87-4.08; P = .010). CONCLUSION: We found SSD to be associated with significant decreases in VAP caused by Gram-positive cocci and H influenzae organisms but no significant differences in VAP caused by nonfermentative bacteria and enterobacteria. Less mean volume of SSD daily was observed in VAP group.


Subject(s)
Drainage/methods , Laryngeal Mucosa , Pneumonia, Ventilator-Associated , Humans , Laryngeal Mucosa/metabolism , Laryngeal Mucosa/microbiology , Laryngeal Mucosa/surgery , Pneumonia, Ventilator-Associated/microbiology , Pneumonia, Ventilator-Associated/prevention & control , Treatment Outcome
6.
Cell Cycle ; 16(23): 2272-2281, 2017.
Article in English | MEDLINE | ID: mdl-28933599

ABSTRACT

SKAP2 (Src kinase-associated phosphoprotein 2), a substrate of Src family kinases, has been suggested to be involved in actin-mediated cellular processes. However, little is known about its role in mouse oocyte maturation. In this study, we thus investigated the expression, localization, and functions of SKAP2 during mouse oocyte asymmetric division. SKAP2 protein expression was detected at all developmental stages in mouse oocytes. Immunofluorescent staining showed that SKAP2 was mainly distributed at the cortex of the oocytes during maturation. Treatment with cytochalasin B in oocytes confirmed that SKAP2 was co-localized with actin. Depletion of SKAP2 by injection with specific short interfering RNA caused failure of spindle migration, polar body extrusion, and cytokinesis defects. Meanwhile, the staining of actin filaments at the oocyte membrane and in the cytoplasm was significantly reduced after these treatments. SKAP2 depletion also disrupted actin cap and cortical granule-free domain formation, and arrested a large proportion of oocytes at the telophase stage. Moreover, Arp2/3 complex and WAVE2 expression was decreased after the depletion of SKAP2 activity. Our results indicate that SKAP2 regulates the Arp2/3 complex and is essential for actin-mediated asymmetric cytokinesis by interacting with WAVE2 in mouse oocytes.


Subject(s)
Actin-Related Protein 2-3 Complex/metabolism , Actins/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Oocytes/metabolism , Wiskott-Aldrich Syndrome Protein Family/metabolism , Actin Cytoskeleton/drug effects , Animals , Cells, Cultured , Cytochalasin B/pharmacology , Female , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins/genetics , Meiosis , Mice , Mice, Inbred ICR , Oocytes/cytology , Polar Bodies/metabolism , RNA Interference , RNA, Small Interfering/metabolism , Spindle Apparatus/metabolism , Telophase
7.
Oncotarget ; 8(4): 6233-6245, 2017 Jan 24.
Article in English | MEDLINE | ID: mdl-28031523

ABSTRACT

Mancozeb, a mixture of ethylene-bis-dithiocarbamate manganese and zinc salts, is one of the most widely used fungicides in agriculture. Mancozeb could lead to mitochondria dysfunction, cellular anti-oxidation enzymes depletion and apoptotic pathways activation. Previous studies indicated the exposure of mancozeb through mother would lead to irregular estrous cycles, decreased progesterone levels, reduced litter sizes, and more frequent delivery of dead fetuses. In this study, we investigated mancozeb inducing reproductive toxicity, especially focusing on its apoptotic effect and epigenetic modifications. We also showed that resveratrol, a kind of phytoalexin found in peanuts and grapes, can alleviate mancozeb's adverse effects, such as declined fertility, decreased ovary weight and primary follicles. Besides, mancozeb treated oocytes displayed suboptimal developmental competence and this can also be improved by treatment of resveratrol. More detailed investigation of these processes revealed that mancozeb increased reactive oxygen species, causing cell apoptosis and abnormal epigenetic modifications, and resveratrol can block these cytotoxic changes. Collectively, our results showed that resveratrol can alleviate mancozeb induced infertility and this was mainly through the correction of apoptotic tendency and the abnormity of cellular epigenetic modification.


Subject(s)
Antioxidants/pharmacology , Apoptosis/drug effects , Fungicides, Industrial/toxicity , Maneb/toxicity , Oocytes/drug effects , Ovarian Follicle/drug effects , Stilbenes/pharmacology , Zineb/toxicity , Animals , Cells, Cultured , Cytoprotection , Epigenesis, Genetic/drug effects , Female , Fertility/drug effects , Gene Expression Regulation, Developmental , Mice, Inbred ICR , Oocytes/metabolism , Oocytes/pathology , Ovarian Follicle/metabolism , Ovarian Follicle/pathology , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Resveratrol
8.
Clin Nephrol ; 84(5): 262-9, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26396095

ABSTRACT

OBJECTIVE: To evaluate the efficacy and safety of calcitriol in the prevention and treatment of glucocorticoid-induced osteoporosis. METHODS: 66 patients treated with glucocorticoids (GC) for primary nephrotic syndrome (NS) were randomly assigned to 3 groups. Groups were designated as follows: calcitriol alone (n = 22), calcitriol plus calcium carbonate (n = 23), or calcium carbonate alone (n = 21). Serum markers of bone metabolism and bone mineral density (BMD) were tested at 3 different time points: the initiation of GC treatment (baseline), 12 weeks, and 24 weeks after the initiation of treatment. RESULTS: Levels of serum 25-hydroxy vitamin D, serum osteocalcin, and total serum collagen type N-terminal extension of the peptide were significantly decreased following GC therapy (p < 0.05). ß-collagen serum-specific sequences were significantly increased following GC therapy. The above-mentioned changes were less dramatic in patients treated with calcitriol, although the differences were significant (p < 0.05). Changes in serum levels of calcium, phosphorus, alkaline phosphatase, and parathyroid hormone (PTH) were not significant. 24 weeks after the initiation of treatment, BMD of the lumbar spine and femoral bone significantly decreased in all of 3 groups. However, patients who received calcitriol had significantly higher BMD of the lumbar spine than patients who received calcium carbonate alone (calcitriol plus calcium carbonate vs. calcium carbonate alone: 0.82 ± 0.19 g/cm2 vs. 0.62 ± 0.23 g/cm2 p < 0.05; calcitriol vs. calcium carbonate alone 0.805 ± 0.203 g/cm2 vs. 0.615 ± 0.225 g/cm2 p < 0.05), respectively. No serious adverse events were observed. CONCLUSION: Calcitriol may be more effective than calcium carbonate in preventing and treating GC-induced osteoporosis in patients with NS.


Subject(s)
Calcitriol/therapeutic use , Glucocorticoids/adverse effects , Nephrotic Syndrome/drug therapy , Osteoporosis/drug therapy , Adult , Alkaline Phosphatase/blood , Bone Density/drug effects , Calcitriol/adverse effects , Calcium Carbonate/therapeutic use , Female , Humans , Male , Middle Aged , Osteocalcin/blood , Osteoporosis/chemically induced , Parathyroid Hormone/blood , Vitamin D/analogs & derivatives , Vitamin D/blood
9.
Nan Fang Yi Ke Da Xue Xue Bao ; 33(10): 1521-4, 2013 Oct.
Article in Chinese | MEDLINE | ID: mdl-24144760

ABSTRACT

OBJECTIVE: To evaluate the clinical efficacy and safety of sequential treatment with alprostadil and beraprost sodium for chronic renal failure caused by chronic glomerulonephritis. METHODS: Sixty-three patients with chronic renal failure due to chronic glomerulonephritis, after receiving a 2-week-long conventional treatment, were randomly divided into alprostadil group (n=20, with alprostadil injection at 10 µg/d for 2 weeks), sequential treatment group (n=21, with alprostadil injection at 10 µg/d for 2 weeks and oral beraprost sodium at 20 µg three times a day for 12 weeks), and strengthened sequential treatment group (n=22, with alprostadil injection at 20 µg/d for 2 weeks and a double dose of oral beraprost sodium for 12 weeks). Urinary albumin excretion rate (UAER), cystatin C (Cys C), blood urea nitrogen, creatinine, fibrinogen, D-dimer, prothrombin time (PT), and platelets were tested before and after the treatment, and the changes in urinary albumin discharge rate, serum creatinine, and glomerular filtration rate were determined. RESULTS: The patients in strengthened sequential treatment group showed a significantly decreased change rate of urinary albumin discharge rate (P<0.01) than those in the other two groups. In the two sequential treatment groups, especially the strengthened treatment group, the change rate of glomerular filtration rate increased significantly compared with that in alprostadil group (P<0.01). Strengthened sequential treatment resulted also in significantly decreased increment of serum creatinine compared that in the other 2 groups (P<0.01). After 14 weeks of treatment, fibrinogen and D-dimer were decreased in all the 3 groups (P<0.05) to a comparable level between the 3 groups (P>0.05), and prothrombin time (PT) or platelet showed no significant changes (P>0.05). CONCLUSION: Sequential treatment with alprostadil and beraprost sodium can improve the glomerular filtration rate and decrease urine albumin excretion rate, serum creatinine increase rate, and lower blood fibrinogen and D-dimer levels, thus delaying the progression of chronic renal failure caused by chronic glomerulonephritis. This therapy shows a dose-related effect with good clinical safety.


Subject(s)
Alprostadil/therapeutic use , Epoprostenol/analogs & derivatives , Glomerulonephritis/complications , Kidney Failure, Chronic/drug therapy , Adolescent , Adult , Aged , Blood Urea Nitrogen , Chronic Disease , Creatinine/blood , Drug Therapy, Combination , Epoprostenol/therapeutic use , Female , Fibrin Fibrinogen Degradation Products/metabolism , Fibrinogen/metabolism , Glomerular Filtration Rate , Humans , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/etiology , Male , Middle Aged , Platelet Aggregation Inhibitors/therapeutic use , Platelet Count , Prothrombin Time , Urological Agents/therapeutic use , Young Adult
10.
Comput Biol Med ; 38(4): 438-45, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18328471

ABSTRACT

Noninvasive pulse waveforms contain rich pathophysiological information of cardiovascular system. It is hereby a tradition of interest to implement risk stratification by pulse waveform monitoring and analysis. In contrast to conventional computer- or network-based solutions, we attempt to accomplish pulse waveform monitoring and analysis within a self-contained mobile platform. It adopts a compact biosensor for pulse waveform acquisition. The collected signals are then submitted to a core board for pulse waveform processing and analysis. In addition, the core board coordinates user interaction and network communication too. Such compact pulse waveform analyzer is of great help for cardiovascular health monitoring at home. A carefully designed evaluation has been undertaken within our research group. The results confirmed its prospect in home healthcare.


Subject(s)
Electrocardiography, Ambulatory/instrumentation , Home Care Services, Hospital-Based , Internet , Pulse , Signal Processing, Computer-Assisted/instrumentation , Telemetry/instrumentation , Adult , Equipment Design , Female , Humans , Male , Microcomputers , Middle Aged , Prospective Studies , Software
SELECTION OF CITATIONS
SEARCH DETAIL
...